SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-014849
Filing Date
2019-05-28
Accepted
2019-05-28 16:17:28
Documents
1
Period of Report
2019-05-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5997
  Complete submission text file 0000899243-19-014849.txt   7397
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O 99 HAYDEN AVE 1 LEDGEMONT CENTER LEXINGTON MA 02173
Business Address
COOPER GLENN L MD (Reporting) CIK: 0001046351 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 19857889